US equities |
MU $1,086.79 ▲+3.94% SNDK $1,725.34 ▲+3.91% NVDA $236.83 ▼-1.01% SPCX $167.46 ▼-2.59% AMD $645.32 ▼-0.63% INTC $112.68 ▲+0.16% TSLA $376.25 ▼-1.17% AAPL $336.96 ▲+1.00%
FinancialContent

Faeth Therapeutics, Inc. - Common Stock (NQ:FTH)

25.80 -1.09 (-4.05%)
Delayed Quote Updated: 2:20 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Faeth Therapeutics, Inc. - Common Stock

News headline image
Sensei Biotherapeutics Highlights PIKTOR Strategy Ahead of Endometrial Trial Readout ↗
Faeth Therapeutics outlined its clinical strategy for PIKTOR, an oral combination designed to inhibit the PI3K/AKT/mTOR, or PAM, pathway at multiple points, during an analyst and investor event. The... 
Via MarketBeat